Intravitreal Injections

AMD is the leading cause of blindness in people over the age of 50. There are two forms of AMD, wet and dry. Both result in deterioration of the retinal tissues and progressive, irreversible blindness. With wet AMD, new blood vessels form resulting in leakage in the diseased area. With dry AMD, more gradual tissue degradation occurs and can result in formation of drusen. Unfortunately, patients with dry AMD, which is the most common form of AMD, are not candidates for currently available drug-based therapies. These drugs are targeted to mechanisms specific to wet AMD. In addition, these therapies are costly, requiring multiple treatments over extended periods of time. Furthermore, drug-based therapies usually only prevent or slow progression of the disease as opposed to restoring lost vision.